HomePDSB • NASDAQ
add
PDS Biotechnology Corp
Previous close
$1.24
Day range
$1.22 - $1.29
Year range
$0.85 - $4.42
Market cap
57.20M USD
Avg Volume
283.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.36M | -29.27% |
Net income | -7.95M | 27.03% |
Net profit margin | — | — |
Earnings per share | -0.21 | 40.00% |
EBITDA | -7.35M | 29.32% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 41.69M | -26.29% |
Total assets | 45.36M | -23.63% |
Total liabilities | 26.35M | -20.76% |
Total equity | 19.00M | — |
Shares outstanding | 45.40M | — |
Price to book | 2.48 | — |
Return on assets | -37.63% | — |
Return on capital | -42.06% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -7.95M | 27.03% |
Cash from operations | -8.23M | 2.63% |
Cash from investing | 0.00 | — |
Cash from financing | 172.78K | -98.40% |
Net change in cash | -8.06M | -449.12% |
Free cash flow | -5.83M | -0.27% |
About
Founded
2005
Website
Employees
24
